Leroy Hood Quotes

Genome-based treatment, based on wider and cheaper availability of genome data, will provide new ways to customize the therapeutic protocol and enhance our control over diseases and medical treatment.

Not only can consumers handle their personal genetic information, but they are getting genomically oriented and anchored about such data.

We need 10,000 genomes, not 100, to start to understand the link between genetics, disease and wellness.

I have had my genome fully sequenced and have learned a great deal about which medications I would respond to and which might or would induce major side effects, along with knowing many medical conditions for which I'm particularly susceptible.

Your genome knows much more about your medical history than you do.

As the knowledge around personalized medicine continues to grow, consumers should expect their healthcare providers to begin to incorporate genetic information into their treatments and preventative care.

My family and I were some of the first people to be genotyped.

The question is, are there useful things that we can do with the results of a genome sequence that would bring benefit? And the answer is, today, should the majority of people go and have their genome sequenced? Probably not. But are there particular circumstances in which genome sequencing is really helpful? Yes, there are.

Once we all have our genomes, some of these extremely rare diseases are going to be totally predictable.

Medicine will be personalized and preventive: Your genome might predict that you have an 80 percent chance of breast cancer by the time you are 50, but if you take a preventive drug starting when you are 40, the chance will drop to 2 percent.

I'm a big believer in what's called personalized medicine, which refers to customizing your health care to your specific needs based on your physiology, genetics, value system and unique conditions.

Making personalized medicine a reality will require a strong partnership between 23andMe and the physician and medical communities.

I do believe at some point in time everyone will be genotyped at birth.

Knowing your genetic health risks will help you make better decisions.

Being the first FDA-authorized direct-to-consumer genetic test out there is revolutionary.

What I really wanted was for everybody to have their genome and, ideally, everybody to share their genome, and for that, we needed to bring the price way down.

I think something very simple that everybody can do is they can participate in medical research as subjects. Personal genome project, for example, will take on as many subjects as we can find.

We are finally entering an exciting time in medicine where we have the technology to custom-tailor treatment and preventive protocols just as we'd custom-tailor a suit or designer gown to one's individual body. But it all begins with you. You have to know yourself in a manner that you've probably never done before.

It is particularly pleasing to see how purely basic research, originally aimed at testing the genetic identity of different cell types in the body, has turned out to have clear human health prospects.

23andMe is pleased to bring public funding to bear on data and research driven by the public - our more than 180,000 customers.

Physicians should be genotyped.

I think there are people who's lives have been saved because of the study of the genome.

I am thrilled to see my genome.

The science of genetics will complicate immensely national health insurance.

You can get so much value just from being genotyped.